Skip to main content
. 2017 May 24;8(46):81285–81294. doi: 10.18632/oncotarget.18150

Table 4. Acute rejection rate before and after CsA shift to FK506.

Genotype GG AA/AG
Drug shift non-shift drug shift non-shift drug shift
before after before after
Patient number (AA/AG) 32 20 20 27 (5/22) 16 (4/12) 16 (4/12)
Acute rejection n(%) 3(9.38%) 7(35%) 2(10.00%) 2(7.41%) 4(25%) 2(12.50%)